LOADING
Tag: Times
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis – Dermatology Times
October 28, 2024
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis Dermatology Times Source link
chat_bubble0 Comment
visibility167 Views
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis – Dermatology Times
October 26, 2024
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis Dermatology Times Source link
chat_bubble0 Comment
visibility171 Views
The Weekly Roundup: October 7-11 – Dermatology Times
October 12, 2024
The Weekly Roundup: October 7-11 Dermatology Times Source link
chat_bubble0 Comment
visibility169 Views
LEO Pharma Presents Prevalence, Severity, and Treatment CHECK Data for Chronic Hand Eczema – Dermatology Times
September 6, 2024
LEO Pharma Presents Prevalence, Severity, and Treatment CHECK Data for Chronic Hand Eczema Dermatology Times Source link
chat_bubble0 Comment
visibility173 Views